Literature DB >> 23441828

Validation and cross-cultural adaptation of the Falls Efficacy Scale in patients with Parkinson's disease in Serbia.

Tatjana Gazibara1, Iva Stankovic, Aleksandra Tomic, Marina Svetel, Darija Kisic Tepavcevic, Vladimir S Kostic, Tatjana Pekmezovic.   

Abstract

AIM: The aim of the present study was to assess the validity and reliability of the Falls Efficacy Scale (FES) in Parkinson's disease (PD) patients in Serbia.
METHODS: A cross-sectional study was carried out at the Clinic for Neurology, between June 2011 and June 2012. A total of 201 consecutive PD outpatients were recruited. The inclusion criteria were: ability to walk independently for at least 10 m, ability to stand for at least 90 s and a Mini-Mental State Examination score >24. The exclusion criteria were: the presence of other major neurological, psychiatric, visual, audio-vestibular and orthopedic disturbances. The 10-item FES was translated according to internationally-accepted methodology. The internal reliability of the Serbian version of the FES was evaluated using Cronbach's alpha coefficient. Reproducibility of the FES was evaluated using the Spearman-Brown coefficient. To evaluate construct validity, an exploratory factor analysis (principal component analysis, varimax rotation) was carried out.
RESULTS: The internal consistency of the Serbian version of the FES was 0.98. Age, duration of disease, Hoehn and Yahr stage, Unified Parkinson's Disease Rating Scale motor score, history of falls, and the Hamilton depression and anxiety scores were significantly correlated with the total FES score. On factor analysis, all 10 items were compact in a one-factor cluster, with an explained variance of 85%. Spearman-Brown's correlation coefficient between the total scores was 0.99.
CONCLUSIONS: The psychometric characteristics of the Serbian version of the FES have excellent reliability and validity as an instrument for measuring the fear of falling in PD patients.
© 2013 Japan Geriatrics Society.

Entities:  

Keywords:  Falls Efficacy Scale; Parkinson's disease; Serbia; reliability; validation

Mesh:

Year:  2013        PMID: 23441828     DOI: 10.1111/ggi.12034

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  6 in total

1.  Incidence and prediction of falls in Parkinson's disease: a prospective cohort study.

Authors:  Tatjana Gazibara; Tatjana Pekmezovic; Darija Kisic-Tepavcevic; Marina Svetel; Aleksandra Tomic; Iva Stankovic; Vladimir S Kostic
Journal:  Eur J Epidemiol       Date:  2015-03-18       Impact factor: 8.082

2.  Dynamics of change in self-reported disability among persons with Parkinson's disease after 2 years of follow-up.

Authors:  Tatjana Gazibara; Darija Kisic-Tepavcevic; Marina Svetel; Aleksandra Tomic; Iva Stankovic; Vladimir Kostic; Tatjana Pekmezovic
Journal:  Neurol Sci       Date:  2017-05-13       Impact factor: 3.307

3.  Factors associated with fear of falling in people with Parkinson's disease.

Authors:  Beata Lindholm; Peter Hagell; Oskar Hansson; Maria H Nilsson
Journal:  BMC Neurol       Date:  2014-01-24       Impact factor: 2.474

4.  Experiences of fear of falling in persons with Parkinson's disease - a qualitative study.

Authors:  Stina B Jonasson; Maria H Nilsson; Jan Lexell; Gunilla Carlsson
Journal:  BMC Geriatr       Date:  2018-02-06       Impact factor: 3.921

5.  Health anxiety and illness-related fears across diverse chronic illnesses: A systematic review on conceptualization, measurement, prevalence, course, and correlates.

Authors:  Sophie Lebel; Brittany Mutsaers; Christina Tomei; Caroline Séguin Leclair; Georden Jones; Danielle Petricone-Westwood; Nicole Rutkowski; Viviane Ta; Geneviève Trudel; Simone Zofia Laflamme; Andrée-Anne Lavigne; Andreas Dinkel
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

6.  Predictive Factors of Concerns about Falling in People with Parkinson's Disease: A 3-Year Longitudinal Study.

Authors:  Magnus Lindh-Rengifo; Stina B Jonasson; Niklas Mattsson; Susann Ullén; Maria H Nilsson
Journal:  Parkinsons Dis       Date:  2019-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.